As many countries are mulling over administering booster shots to safeguard people from newer Covid-19 variants, big pharma giant Moderna recommends a third vaccine dose
Vials with a sticker reading,"COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020.
All three of the current Covid-19 vaccines on the market in the US are believed to offer protection from the more contagious Delta variant. In rare "breakthrough" cases, in which vaccinated people get the virus, symptoms are generally mild or non-existent.Bancel said the company is working on a booster shot that he envisions being a single-shot vaccine that would be doled once a year and would protect against Covid-19 and the basic flu.
The moves come as vaccine hesitancy in parts of the US, even vaccine hostility, is helping the spread of the Delta variant. But the White House is reporting that in areas where hospitalizations have been surging, vaccination rates are starting to tick up.The US on Wednesday rebuffed a call from the World Health Organization to impose a worldwide coronavirus booster shot moratorium, saying it presents "a false choice.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: One more Covid-linked death and 1,040 new casesThe total number of Covid-19 vaccines administered in Northern Ireland is now 2,284,540.
Read more »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Read more »
Malaysia grants conditional approval for Moderna COVID-19 vaccineMalaysia's Health Ministry on Thursday said it has granted a conditional approval for the Moderna COVID-19 vaccine for emergency use.
Read more »
Moderna says its COVID-19 shot provides 93% immunity after six monthsModerna Inc.'s undefined said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its second-quarter earnings...
Read more »
COVID-19 live updates: Moderna vaccine 93% effective against symptomatic disease after 6 monthsModerna says its COVID vaccine is 93% effective against symptomatic illness after six months (though this data collection ended before delta emerged in the U.S.).
Read more »
Moderna Recommends Covid-19 Vaccine Booster to Protect Against New VariantsModerna said people who received its Covid-19 vaccine will likely need a booster shot before the winter to keep strong protection against newer variants
Read more »